Foresite Capital Management II as of June 30, 2017
Portfolio Holdings for Foresite Capital Management II
Foresite Capital Management II holds 13 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aerie Pharmaceuticals | 40.3 | $88M | 1.7M | 52.55 | |
| Aimmune Therapeutics | 37.6 | $82M | 4.0M | 20.56 | |
| Epizyme | 10.3 | $22M | 1.5M | 15.10 | |
| Alder Biopharmaceuticals | 5.5 | $12M | 1.0M | 11.45 | |
| Nanostring Technologies (NSTGQ) | 1.9 | $4.2M | 254k | 16.54 | |
| Dermira | 1.8 | $3.9M | 135k | 29.14 | |
| Orexigen Therapeutics | 0.8 | $1.7M | 602k | 2.90 | |
| Jounce Therapeutics | 0.8 | $1.7M | 120k | 14.03 | |
| Akebia Therapeutics (AKBA) | 0.3 | $719k | 50k | 14.38 | |
| Bellicum Pharma | 0.3 | $591k | 51k | 11.69 | |
| Sangamo Biosciences (SGMO) | 0.2 | $405k | 46k | 8.80 | |
| Zafgen | 0.2 | $420k | 120k | 3.51 | |
| Ardelyx (ARDX) | 0.1 | $191k | 38k | 5.09 |
